As federal rescheduling advances, unresolved transparency gaps remain in South Dakota’s medical market. South Dakota’s Medical Cannabis Program is designed to operate through patient, caregiver, practitioner, and establishment fees rather than ordinary general-fund appropriations.¹ But a fee-funded program still creates public administrative costs. Enforcement actions require inspectors, lawyers, agency leadership, public notices, patient communications, litigation … Continue reading South Dakota Patients and Taxpayers Deserve More Transparency in Medical Cannabis Enforcement